CV Sciences, Inc. (CVSI)
OTCMKTS: CVSI · Delayed Price · USD
0.0500
-0.0020 (-3.85%)
Jul 2, 2024, 3:09 PM EDT - Market closed
CV Sciences Revenue
CV Sciences had revenue of $15.86M in the twelve months ending March 31, 2024, down -0.30% year-over-year. Revenue in the quarter ending March 31, 2024 was $4.00M, a -3.52% decrease year-over-year. In the year 2023, CV Sciences had annual revenue of $16.00M, a decrease of -1.24%.
Revenue (ttm)
$15.86M
Revenue Growth
-0.30%
P/S Ratio
0.51
Revenue / Employee
$377,571
Employees
42
Market Cap
8.16M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.00M | -201.00K | -1.24% |
Dec 31, 2022 | 16.21M | -3.84M | -19.17% |
Dec 31, 2021 | 20.05M | -4.38M | -17.93% |
Dec 31, 2020 | 24.43M | -29.27M | -54.50% |
Dec 31, 2019 | 53.70M | 5.45M | 11.30% |
Dec 31, 2018 | 48.24M | 27.56M | 133.30% |
Dec 31, 2017 | 20.68M | 9.62M | 86.96% |
Dec 31, 2016 | 11.06M | -468.77K | -4.07% |
Dec 31, 2015 | 11.53M | 1.34M | 13.14% |
Dec 31, 2014 | 10.19M | 8.04M | 373.09% |
Dec 31, 2013 | 2.15M | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
CVSI News
- 7 weeks ago - CV Sciences, Inc. Reports First Quarter 2024 Financial Results - PRNewsWire
- 7 weeks ago - CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER - PRNewsWire
- 7 weeks ago - CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024 - PRNewsWire
- 3 months ago - CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results - PRNewsWire
- 3 months ago - CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews - PRNewsWire
- 3 months ago - CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024 - PRNewsWire
- 7 months ago - CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution - PRNewsWire
- 8 months ago - CV Sciences, Inc. Reports Third Quarter 2023 Financial Results - PRNewsWire